Search results
Author(s):
Leslie Marisol Lugo
,
Rafael Romaguera
,
Joan Antoni Gómez-Hospital
,
et al
Added:
3 years ago
Transcatheter aortic valve implantation (TAVI) is the therapy of choice for patients with symptomatic severe aortic stenosis who are unsuitable for surgical aortic valve replacement and for elderly patients with high operative risk.1,2 It is also considered to be a more than valid and reasonable alternative to surgical aortic valve replacement for patients with moderate to high surgical risk.3,4…
View more
Author(s):
Christopher P Cannon
Added:
6 years ago
This interview with Christopher P. Cannon from Brigham and Women's Hospital, Boston, US discusses Dual Antithrombotic Therapy with Dabigatran After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation (REDUAL-PCI).
Filmed by Radcliffe Cardiology on-site at ESC 2017.
View more
Author(s):
David Berg
Added:
1 year ago
ESC Congress 22 — Dr David Berg (Brigham and Women's Hospital, US) shares key results from the TIMI Study Group's COVID-PACT trial (NCT04409834).
This multicenter, randomized-controlled trial assessed efficacy and safety of full-dose vs. standard prophylactic dose anticoagulation and of antiplatelet vs. no antiplatelet therapy for prevention of venous and arterial thrombotic events. The study…
View more
Author(s):
Maria Cristina Beznă
,
Suzana Dănoiu
,
Marinela Beznă
,
et al
Added:
12 months ago
Author(s):
George D Dangas
Added:
2 years ago
In this short video, Dr George Dangas (Mount Sinai Hospital, New York, NY, US) shares the findings from the ENVISAGE-TAVI AF hot line trial presented at ESC Congress 2021.
ENVISAGE-TAVI AF (Daiichi-Sankyo) compared the safety and efficacy of the DOAC edoxaban with VKAs (warfarin and its analogues) in atrial fibrillation patients with an indication for oral anticoagulation after successful TAVI.
…
View more
Author(s):
Emmanuel Sorbets
,
Philippe Gabriel Steg
Added:
3 years ago
Despite improvements in the management of coronary artery disease over the last decades, ischaemic heart disease remains the leading cause of mortality worldwide and the leading cause of premature death.1,2 Patients with chronic coronary syndromes (CCS) encompass a heterogeneous population, including those with demonstrable coronary artery disease by anatomical testing or evidence of ischaemia,…
View more
Boyoung Joung
Research Area(s) / Expertise:
Author
Author(s):
Nadzeya Kuzniatsova
,
Gregory YH Lip
Added:
3 years ago
Atrial fibrillation (AF) is the most common cardiac rhythm disorder in everyday clinical practice, affecting 1–2% of the general population. The prevalence of AF is strongly age-dependent, increasing from <1% in patients under 60 years of age to almost 10% in patients 80 years of age or older1 and 17.8% in those 85 years of age and above.2 Population-based studies have shown lifetime risks for…
View more
John Eikelboom
Research Area(s) / Expertise:
Job title: Associate Professor
Author
Kurt Huber
Job title: Head of the 3rd Med. Dept. of Cardiology and Internal Intensive Care Medicine
Author